AUD 0.1
(-3.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.56 Million | -3.87 Million | -5.17 Million | -1.97 Million | -2.49 Million | -3.52 Million |
Net Income | -2.94 Million | -5.09 Million | -3.59 Million | -3.77 Million | -2.62 Million | -2.71 Million |
Depreciation & Amortization | 163.46 Thousand | 159.93 Thousand | 133.06 Thousand | 84.55 Thousand | 38.96 Thousand | 70.28 Thousand |
Deferred income taxes | - | -830.14 Thousand | -1.06 Million | 80.37 Thousand | - | -1.5 Million |
Stock-based compensation | 362.83 Thousand | 123.28 Thousand | 646.33 Thousand | 594.53 Thousand | - | 1.18 Million |
Change in working capital | 245.66 Thousand | -419.87 Thousand | -80.33 Thousand | 995.52 Thousand | 41.18 Thousand | -180.67 Thousand |
Other non-cash items | 602.1 Thousand | 2.18 Million | -1.21 Million | 40.95 Thousand | 137.76 Thousand | -371.67 Thousand |
Investing Cash Flow | -491.39 Thousand | -2.14 Million | -5.95 Million | -1.95 Million | -12.82 Thousand | 4.4 Million |
Investments in PPE | -589.43 Thousand | -2.14 Million | -5.96 Million | -1.95 Million | -12.82 Thousand | -86.96 Thousand |
Acquisitions | - | - | - | - | - | 4.18 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -476.43 Thousand | 45.96 Thousand | 10.05 Thousand | 2917.00 | 34.92 Thousand | 300 Thousand |
Financing Cash Flow | 3.34 Million | 4.59 Million | 4.16 Million | 10.5 Million | -8334.00 | 3719.00 |
Debt repayment | -197.85 Thousand | -240 Thousand | -240 Thousand | -1 Million | -8926.00 | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 3.62 Million | 4.89 Million | 4.47 Million | 11.63 Million | 592.00 | 3719.00 |
Other Financing Activities | -80.14 Thousand | -64.21 Thousand | -69.23 Thousand | -127.36 Thousand | 592.00 | 3719.00 |
Accounts receivables | 320.34 Thousand | -178.67 Thousand | 269.45 Thousand | -397.24 Thousand | 285.06 Thousand | -274.11 Thousand |
Accounts payables | -94.32 Thousand | -208.32 Thousand | -423.42 Thousand | 1.24 Million | -289.63 Thousand | 93.44 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -74.67 Thousand | -32.87 Thousand | 73.63 Thousand | 151.5 Thousand | 45.75 Thousand | - |
Cash at beginning of period | 423.51 Thousand | 1.91 Million | 8.82 Million | 2.25 Million | 4.76 Million | 3.88 Million |
Cash at end of period | 1.7 Million | 497.81 Thousand | 1.84 Million | 8.82 Million | 2.25 Million | 4.76 Million |
Capital Expenditure | -589.43 Thousand | -2.14 Million | -5.96 Million | -1.95 Million | -12.82 Thousand | -86.96 Thousand |
Effect of forex changes on cash | - | - | -10.04 Thousand | -2918.00 | - | - |
Net cash flow / Change in cash | 1.28 Million | -1.42 Million | -6.97 Million | 6.56 Million | -2.51 Million | 881.45 Thousand |
Free Cash Flow | -2.15 Million | -6.01 Million | -11.14 Million | -3.93 Million | -2.5 Million | -3.6 Million |
Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -843.16 Thousand | -843.16 Thousand | -626.83 Thousand | -626.83 Thousand | -5.09 Million | -3.12 Million |
Depreciation & Amortization | 40.8 Thousand | 40.8 Thousand | 40.93 Thousand | 40.93 Thousand | 159.93 Thousand | 81.11 Thousand |
Deferred income taxes | - | - | -124.4 Thousand | - | -830.14 Thousand | -28.58 Thousand |
Stock-based compensation | 83.91 Thousand | 83.91 Thousand | 97.5 Thousand | 97.5 Thousand | 123.28 Thousand | 23.66 Thousand |
Change in working capital | -252.53 Thousand | -252.53 Thousand | 375.36 Thousand | 375.36 Thousand | -419.87 Thousand | -24.63 Thousand |
Other non-cash items | 641.8 Thousand | 641.8 Thousand | -340.75 Thousand | -340.75 Thousand | 2.18 Million | 1.75 Million |
Investing Cash Flow | -31.83 Thousand | -31.83 Thousand | -213.86 Thousand | -213.86 Thousand | -2.14 Million | -848.89 Thousand |
Investments in PPE | -59.24 Thousand | -59.24 Thousand | -235.47 Thousand | -235.47 Thousand | -2.14 Million | -848.89 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 27.41 Thousand | 27.41 Thousand | 21.6 Thousand | 21.6 Thousand | 45.96 Thousand | 8450.00 |
Financing Cash Flow | -63.99 Thousand | -63.99 Thousand | 1.73 Million | 1.73 Million | 4.59 Million | -176.06 Thousand |
Debt repayment | -87.73 Thousand | - | -110.11 Thousand | - | -240 Thousand | -119.67 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -13.00 | -13.00 | - | - | - | -15.9 Thousand |
Common Stock Issuance | -27.00 | - | 3.62 Million | - | 4.89 Million | -31.81 Thousand |
Other Financing Activities | -63.98 Thousand | -63.98 Thousand | 1.73 Million | 1.73 Million | -64.21 Thousand | -72.12 Thousand |
Accounts receivables | -188.15 Thousand | -188.15 Thousand | 348.32 Thousand | 348.32 Thousand | -178.67 Thousand | -126.46 Thousand |
Accounts payables | 465.5 Thousand | - | -559.83 Thousand | - | -208.32 Thousand | 283.76 Thousand |
Inventory | - | - | - | - | - | -1.00 |
Other working capital | -64.37 Thousand | -64.37 Thousand | 27.03 Thousand | 27.03 Thousand | -32.87 Thousand | -181.94 Thousand |
Cash at beginning of period | 2.63 Million | - | 497.81 Thousand | - | 1.91 Million | 2.83 Million |
Cash at end of period | 1.78 Million | -424.99 Thousand | 2.63 Million | 1.06 Million | 497.81 Thousand | 497.81 Thousand |
Capital Expenditure | -59.24 Thousand | -59.24 Thousand | -235.47 Thousand | -235.47 Thousand | -2.14 Million | -848.89 Thousand |
Effect of forex changes on cash | - | - | - | - | - | 1.00 |
Net cash flow / Change in cash | -849.99 Thousand | -424.99 Thousand | 2.13 Million | 1.06 Million | -1.42 Million | -2.34 Million |
Free Cash Flow | -388.41 Thousand | -388.41 Thousand | -689.26 Thousand | -689.26 Thousand | -6.01 Million | -2.16 Million |
STQN
BCJ
AMPGW
VNTA
RTMFF
000727